Connect with us

Published

on

Larry Ellison, co-founder and executive chairman of Oracle Corp., speaks during the Oracle OpenWorld conference in San Francisco on Oct. 22, 2018.

David Paul Morris | Bloomberg | Getty Images

Oracle unveiled a brand-new electronic health record on Tuesday, its most significant health-care product update since acquiring the medical records giant Cerner for $28 billion in 2022. 

An electronic health record, or an EHR, is a digital version of a patient’s medical history that’s updated by doctors and nurses over time. EHR software can be complex and cumbersome for clinicians to use, but it’s become an integral component of the modern U.S. health-care system.   

Oracle’s latest EHR is equipped with cloud and artificial intelligence capabilities that will make it easier to navigate and set up, the company said. There are no menus or drop-down screens, and doctors can pull up the information they need by asking questions with their voices. Ideally, this will allow doctors to spend less time searching through records and more time caring for patients, Oracle said. 

“It’s not just a scribe. It’s not an assistant. It’s almost like having your own resident,” Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, told CNBC in an interview. 

Oracle’s new offering could help boost its position within the fiercely competitive EHR market, where it has struggled to maintain its footing in recent years. In 2023, Oracle saw its largest net hospital loss on record while market leader Epic Systems, Oracle’s top rival, was the only company that saw a net increase in acute care market share, according to a report from KLAS Research.

Cerner contributed $5.9 billion to Oracle’s total revenue in fiscal 2023. Epic generated $4.9 billion in revenue last year. 

Oracle co-founder and Chairman Larry Ellison delivers a keynote address during the Oracle OpenWorld on October 22, 2018 in San Francisco, California. 

Justin Sullivan | Getty Images

The new EHR has been in the works since Oracle acquired Cerner, but it was not built on top of Cerner’s existing infrastructure, Verma said. That means current Cerner customers will have to decide whether to migrate to the separate system.

“Just think about crumbling infrastructure in a house, you’re not going to put new things on top of it,” she said. “That was the conclusion that we came to when we looked at the Cerner technology, so what we’re introducing to the market is something that’s brand new.”

Suhas Uliyar, Oracle’s senior vice president for product management in clinical and health-care AI, walked CNBC through a virtual demo of the new EHR. He showcased what it might look like for a doctor to get up to speed, respond to messages and fill prescriptions ahead of a day packed full of patient visits.  

The EHR is browser based, and physicians will see a search bar and a chronological list of their appointments when they open it. The interface is very simple. A doctor can click on the microphone in the search bar and ask questions like, “How many openings do I have for today?” or “How many new patients do I have on schedule for today?” The doctor will then get an AI-generated answer within seconds. 

If a doctor clicks on a patient, they’ll open their chart, where they can find AI summaries as well as more detailed explanations of their medical history. The physician can see what’s changed since the patient’s last visit, whether they’re taking any new medication and other details like lab results, clinical documentation, past treatments, risk factors, messages, allergies and vitals. 

Additionally, the doctor can click the microphone and ask patient-specific questions like “Has she ever complained about panic attacks or shortness of breath?,” “Has he had a CT screening for lung cancer, and are his vaccinations up to date?” or “Which antibiotics have you treated her urinary tract infection with?”

“It’s going through the entire history, all the records, and it gives me a very specific answer,” Uliyar said. “I didn’t have to go scroll through 15 different documents and find that.” 

The voice-activated questions can build on one another, and the EHR’s AI will start to learn the doctor’s habits, like the types of medications they prescribe and refill often. Even when Uliyar stumbled over his words or didn’t phrase a question exactly right, the system still pulled up the information he was looking for.   

If a doctor wants to go into more detail or double-check an AI-generated answer within the new EHR, they can always click on the citation and look through the original record that’s referenced, Uliyar said. And answers that include content like medication dosage information or other evidence-based recommendations will link to validated databases, he added.  

Traders work on the floor of the New York Stock Exchange (NYSE) on July 12, 2023 in New York City. 

Spencer Platt | Getty Images

While Oracle has been developing its new EHR, the company has also been rolling out features to existing Cerner customers to try and improve their experience with the product. Uliyar said many of these features, including Oracle Health Clinical AI Agent (formerly called Oracle Clinical Digital Assistant), are already embedded within the new EHR. 

Oracle announced the general availability of Clinical AI Agent in June, and it aims to automate much of the documentation that doctors are responsible for. 

Physicians can access the Clinical AI Agent through an app on their phone, and they hit a button to record their visits with patients. Once they stop recording, Oracle’s AI automatically generates a clinical note based on the appointment, so the doctors no longer need to write it themselves. 

Around 70 customers are already using the Clinical AI Agent, Uliyar said. The company is currently building a similar tool for nurses. 

Since the Clinical AI Agent is already embedded within the new EHR, customers will not have to worry about integrating it. The tool will also remain available as a stand-alone product that’s EHR agnostic, Uliyar said. 

The early adopter program for Oracle’s new EHR begins next year, and Oracle said it will work with customers to determine the customizations they need. The company has been moving its health-care customers to the cloud, so that should make the EHR implementation process much easier, Verma said.

“We see it as very disruptive to the market,” she said. “Our EHR is going to solve a lot of long-standing problems that we’ve had in health care.”

Don’t miss these insights from CNBC PRO

Oracle has been a 'hidden story' as they shifted to the cloud, says Bernstein's Mark Moerdler

Continue Reading

Technology

Figure AI sued by whistleblower who warned that startup’s robots could ‘fracture a human skull’

Published

on

By

Figure AI sued by whistleblower who warned that startup's robots could 'fracture a human skull'

Startup Figure AI is developing general-purpose humanoid robots.

Figure AI

Figure AI, an Nvidia-backed developer of humanoid robots, was sued by the startup’s former head of product safety who alleged that he was wrongfully terminated after warning top executives that the company’s robots “were powerful enough to fracture a human skull.”

Robert Gruendel, a principal robotic safety engineer, is the plaintiff in the suit filed Friday in a federal court in the Northern District of California. Gruendel’s attorneys describe their client as a whistleblower who was fired in September, days after lodging his “most direct and documented safety complaints.”

The suit lands two months after Figure was valued at $39 billion in a funding round led by Parkway Venture Capital. That’s a 15-fold increase in valuation from early 2024, when the company raised a round from investors including Jeff Bezos, Nvidia, and Microsoft.

In the complaint, Gruendel’s lawyers say the plaintiff warned Figure CEO Brett Adcock and Kyle Edelberg, chief engineer, about the robot’s lethal capabilities, and said one “had already carved a ¼-inch gash into a steel refrigerator door during a malfunction.”

The complaint also says Gruendel warned company leaders not to “downgrade” a “safety road map” that he had been asked to present to two prospective investors who ended up funding the company.

Gruendel worried that a “product safety plan which contributed to their decision to invest” had been “gutted” the same month Figure closed the investment round, a move that “could be interpreted as fraudulent,” the suit says.

The plaintiff’s concerns were “treated as obstacles, not obligations,” and the company cited a “vague ‘change in business direction’ as the pretext” for his termination, according to the suit.

Gruendel is seeking economic, compensatory and punitive damages and demanding a jury trial.

Figure didn’t immediately respond to a request for comment. Nor did attorneys for Gruendel.

The humanoid robot market remains nascent today, with companies like Tesla and Boston Dynamics pursuing futuristic offerings, alongside Figure, while China’s Unitree Robotics is preparing for an IPO. Morgan Stanley said in a report in May that adoption is “likely to accelerate in the 2030s” and could top $5 trillion by 2050.

Read the filing here:

AI is turbocharging the evolution of humanoid robots, says Agility Robotics CEO

Continue Reading

Technology

Here are real AI stocks to invest in and speculative ones to avoid

Published

on

By

Here are real AI stocks to invest in and speculative ones to avoid

Continue Reading

Technology

The Street’s bad call on Palo Alto – plus, two portfolio stocks reach new highs

Published

on

By

The Street's bad call on Palo Alto – plus, two portfolio stocks reach new highs

Continue Reading

Trending